News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • BofA released a Fed-watching primer detailing the Fed's mandate, FOMC votes, new communication, policy tools, and balance-sheet metrics.
  • Analysts recommend a defensive short on Salesforce, citing metered AI monetization and broken technical momentum, target $130.
  • IREN pivoted to AI-first data centers with Nvidia and Dell contracts and expanded European capacity, prompting bullish trade setups.
  • A buy-write strategy on ITWO could yield about 7.5% annually while retaining upside optionality to roughly $50.
  • Analysts emphasize tactical, mid-term swing trades across AI, cloud, and yield products amid ongoing Fed policy monitoring.

Latest Articles

Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar

Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar

Clearmind Medicine Inc., a clinical-stage biotech company specializing in non-hallucinogenic neuroplastogen-derived therapeutics, will host a live webinar on June 10, 2026 to discuss new clinical data from its ongoing FDA-approved Phase I/IIa trial of CMND-100, a MEAI-based oral drug candidate for Alcohol Use Disorder treatment. The webinar feature…

TD Cowen Lifts 2030 Global GLP-1 Sales Forecast to $150 Billion

TD Cowen Lifts 2030 Global GLP-1 Sales Forecast to $150 Billion

TD Cowen has upgraded its estimate for global sales of GLP-1 therapies to $150 billion by 2030, up from $139 billion, and now anticipates about 59 million patients receiving treatment by that year. The firm expects oral weight-loss formulations to secure a larger slice of the market and projects continued dominance by Eli Lilly and Novo Nordisk.

Buying Broadcom After the Drop: Tactical Long on a Calmer AI Story

Buying Broadcom After the Drop: Tactical Long on a Calmer AI Story

Broadcom shares plunged after guidance disappointed overheated expectations, but the underlying business still shows rapid AI revenue growth, strong free cash flow, and heavyweight customers. This trade targets a mid-term rebound back toward the stock's recent highs while keeping a tight stop to limit downside if guidance proves conservative.

SpaceX Bars Investors in China and Hong Kong From $75 Billion IPO

SpaceX Bars Investors in China and Hong Kong From $75 Billion IPO

SpaceX has directed underwriters for its planned $75 billion initial public offering to refuse investment orders originating from Hong Kong and mainland China, according to people briefed on the matter. The company also restricted access to its website from internet addresses in Hong Kong and Shanghai, and banks working on the deal pointed to U.S. …

Kepler Upgrades Vestas to Buy as Order Volumes Reach Six-Year High

Kepler Upgrades Vestas to Buy as Order Volumes Reach Six-Year High

Kepler Cheuvreux has raised its recommendation on Vestas Wind Systems A/S from Hold to Buy, pointing to a more attractive risk-reward profile following recent share price weakness and the company's strongest order intake volumes in nearly six years. The broker's analysis highlights supportive European policy moves, stable turbine pricing, normalize…

Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027

Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027

Seres Therapeutics announced two financial transactions: a $25 million milestone buy-out agreement with Nestlé Health Science for their former VOWST business, and a restructured lease agreement reducing ongoing costs. These moves improve Seres' balance sheet, lower facility expenses, and extend their operating cash runway well into the first quarte…

Portillo’s Comes Home to the Heart of Chicago with Plans to Open Landmark Michigan Avenue Restaurant

Portillo’s Comes Home to the Heart of Chicago with Plans to Open Landmark Michigan Avenue Restaurant

Portillo's, a Chicago-born fast-casual restaurant chain known for Italian beef sandwiches and Chicago-style hot dogs, is opening a new flagship restaurant on Michigan Avenue, marking its first inline location in Chicago and continuing its expansion. This location emphasizes the brand's connection to its roots and reflects a broader growth strategy …